NCT00427349 2023-07-05AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsEastern Cooperative Oncology GroupPhase 2 Completed46 enrolled 7 charts
NCT00131911 2014-11-17Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine TumorsNational Cancer Institute (NCI)Phase 2 Completed93 enrolled 10 charts